Teva Pharmaceutical Industries Limited reports Impairment of long-lived assets for the three months ended March 31, 2024. For the quarter, the company reported Impairment of long-lived assets of $679 million against $188 million a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.82 USD | +0.33% | +3.38% | +61.30% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.30% | 18.98B | |
+38.83% | 728B | |
+33.05% | 603B | |
-5.16% | 360B | |
+19.88% | 332B | |
+1.85% | 279B | |
+16.25% | 244B | |
+8.06% | 207B | |
-5.69% | 205B | |
+6.41% | 164B |
- Stock Market
- Equities
- TEVA Stock
- News Teva Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Limited Reports Impairment of Long-Lived Assets for the Three Months Ended March 31, 2024